Fig. 3: Synergistic efficacy and selectivity of combined RT and GB13 in vitro. | Communications Biology

Fig. 3: Synergistic efficacy and selectivity of combined RT and GB13 in vitro.

From: Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma

Fig. 3

A, B Western blot of DIPG cell lines with increasing IL-13Rα2 expression (SU-DIPG XIII, SU-DIPG XVII, SF8628, and SU-DIPG IV) treated for 72 h with vehicle control, GB13 alone at IC50, RT alone, or RT plus GB13 at IC50 (added 24 h pre-RT). A GAPDH and B Total Histone H3 are the loading controls.

Back to article page